medicalxpress - Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are just as likely as those…
AI Summary: A national study has been launched to assess whether genetic testing can refine follow-up care for cancer survivors, tailoring surveillance to individual risk and potentially reducing unnecessary tests. The large-scale effort seeks to integrate genomic data into survivorship plans to better predict late effects and allocate resources to those most likely to benefit.
ctDNA blood test pinpoints who needs chemo after colorectal liver surgery / 4 days
Early‑onset cancers rising; family history crucial for prevention / 20 days
Ultrasensitive HPV blood test detects head and neck recurrence months earlier / 29 days
Prosigna-guided OPTIMA trial shows chemo can be safely skipped in many ER+/HER2− breast cancers / 5 wks
Liquid biopsy blood test promises personalized lung cancer detection and monitoring / 6 wks
Jeremy Clarkson treated for aggressive prostate cancer, now in remission / 16 days
UCLA unveils low-cost blood test to detect multiple cancers from one sample / 3 months
StackHealth RSS


StackHealth Time Machine
NorthFeed Inc. Terms and Conditions / Privacy Policy
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.